Preoperative MRI, Clinical Examination, and Mammography for Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial

OBJECTIVE. The objective of our study was to determine the accuracy of preoperative measurements for detecting pathologic complete response (CR) and assessing residual disease after neoadjuvant chemotherapy (NACT) in patients with locally advanced breast cancer. SUBJECTS AND METHODS. The American Co...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:AJR Am J Roentgenol
Auteurs principaux: Scheel, John R., Kim, Eunhee, Partridge, Savannah C., Lehman, Constance D., Rosen, Mark A., Bernreuter, Wanda, Pisano, Etta D., Marques, Helga, Morris, Elizabeth A., Weatherall, Paul T., Polin, Sandra M., Newstead, Gillian M., Esserman, Laura J., Schnall, Mitchell D., Hylton, Nola M.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6615034/
https://ncbi.nlm.nih.gov/pubmed/29708782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2214/AJR.17.18323
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires